A framework for cost-effectiveness analysis from clinical trial data

被引:64
|
作者
O'Hagan, A
Stevens, JW
机构
[1] Univ Sheffield, Dept Probabil & Stat, Stat Serv Unit, Sheffield S3 7RH, S Yorkshire, England
[2] Astra Zeneca R&D Charnwood, Loughborough, Leics, England
关键词
Bayesian analysis; cost-effectiveness acceptability curve; log-normal distribution; net benefit; normal distribution; outcomes;
D O I
10.1002/hec.617
中图分类号
F [经济];
学科分类号
02 ;
摘要
We present a general Bayesian framework for cost-effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mean efficacy and mean cost to the parameters of any given model. Examples are given in which efficacy may be measured as a continuous, binary, ordinal or time-to-event outcome, and in which costs are modelled as distributed normally, log-normally, as a mixture or non-parametrically. A case study is presented, illustrating the methodology and illuminating the role of prior information. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 315
页数:13
相关论文
共 50 条
  • [21] Cost-effectiveness analysis alongside clinical trials
    Bossuyt, PMM
    [J]. EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 37 - 45
  • [22] Cost-effectiveness analysis of national clinical guidelines
    Van Os, N
    Niessen, LW
    Casparie, AF
    Van Hout, BA
    [J]. DIABETES, 1999, 48 : A416 - A416
  • [23] COST-EFFECTIVENESS ANALYSIS FOR CLINICAL PROCEDURES IN ONCOLOGY
    WEINSTEIN, MC
    [J]. BULLETIN DU CANCER, 1980, 67 (05) : 491 - 500
  • [24] Cost-effectiveness analysis for multinational clinical trials
    Pinto, EM
    Willan, AR
    O'Brien, BJ
    [J]. STATISTICS IN MEDICINE, 2005, 24 (13) : 1965 - 1982
  • [25] COST-EFFECTIVENESS ANALYSIS AND CLINICAL-PRACTICE
    RECTOR, TS
    FRANCIS, GS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (04) : 920 - 921
  • [26] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [27] COST-EFFECTIVENESS ANALYSIS OF INTERVENTIONS THAT HAVE NOT SHOWN CLINICAL EFFECTIVENESS
    Teljeur, C.
    Harrington, P.
    O'Neill, M.
    Moran, P.
    Ryan, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A751 - A751
  • [28] Cost-effectiveness of clopidogrel in Mexico: Within trial analysis
    Jerjes-Sanchez, C.
    Trujillo, A.
    Ramos, M. A.
    Hernandez, I
    Alvarado, R.
    Cruz, A.
    Rangel, F. J.
    Morales, E.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A344 - A344
  • [29] Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set
    Dakin, Helen
    Gray, Alastair
    Fitzpatrick, Ray
    MacLennan, Graeme
    Murray, David
    [J]. BMJ OPEN, 2012, 2 (01):
  • [30] A trial of the clinical and cost-effectiveness of a supervised exercise programme for claudication
    Lee, HLD
    Mehta, T
    Ray, B
    Heng, MST
    McCollum, PT
    Chetter, IC
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 : 11 - 11